share_log

Cannibble Announces LOI for Acquisition of Eshbal Functional Foods an Israeli Food Tech Manufacturer

Cannibble Announces LOI for Acquisition of Eshbal Functional Foods an Israeli Food Tech Manufacturer

Cannibble宣布收购以色列食品技术制造商Eshbal Functional Foods的意向书
newsfile ·  2022/08/29 08:10

Rosh Haayin, Israel--(Newsfile Corp. - August 29, 2022) - Cannibble Foodtech Ltd., (CSE: PLCN) ("Cannibble" or the "Company"), an Israeli food-tech company that develops and manufactures food and beverage products that are enhanced variously with hemp seeds, hemp protein, and other hemp ingredients, where legal to do so, is pleased to announce that it has entered into a partially binding letter of intent with Eshbal Functional Foods Cooperative Ltd. ("Eshbal") contemplating the acquisition (the "Proposed Acquisition") by Cannibble of all the outstanding membership interests of Eshbal from the members of Eshbal (the "Vendors"). If completed, the Proposed Acquisition will expand Cannibble's business in the global health and wellness market.

以色列Rosh Haayin-(Newsfile Corp.-2022年8月29日)-Cannibble FoodTech Ltd.(CSE:PLCN)(““罐头炸弹”“或”公司),一家以色列食品技术公司,开发和制造使用大麻种子、大麻蛋白和其他大麻成分进行不同程度增强的食品和饮料产品,在合法的情况下这样做是合法的,该公司高兴地宣布,它已经与Eshbal Functional Foods Coop Ltd.()签订了一份具有部分约束力的意向书。以实巴勒“)考虑收购(The”拟议中的收购“)Cannibble从Eshbal的成员那里获得Eshbal所有未偿还的成员权益(The”卖主如果完成,拟议中的收购将扩大Cannibble在全球健康和保健市场的业务。

Eshbal is a private Israeli food manufacturer established in 1940. Eshbal develops and produces unique formulations of: nutraceuticals, medicinal foods, sugar-free and gluten-free products, vegan products, syrups, and dry mixes including sweeteners. Eshbal focuses on the development of unique formulations of functional foods that it believes promote health beyond their nutritional values, incorporating development and production capabilities for retail brands, private labels, and B2B. Eshbal's production and R&D capabilities include development of propriety formulations, mixing of various powders and cereals, cooking and preparation of syrups and spreads, baking of gluten-free, sugar-free, keto-friendly through diverse packaging technologies. Eshbal's gluten free products can be found in almost every supermarket as well as other food retailers and health stores throughout Israel.

Eshbal是一家以色列私营食品制造商,成立于1940年。Eshbal开发和生产以下产品的独特配方:营养食品、药用食品、无糖和无麸质产品、素食产品、糖浆和包括甜味剂在内的干混合物。Eshbal专注于开发其认为超越其营养价值促进健康的独特功能食品配方,整合了零售品牌、自有品牌和B2B的开发和生产能力。Eshbal的生产和研发能力包括开发合适的配方,混合各种粉末和谷类食品,烹饪和制备糖浆和糖浆,通过不同的包装技术烘焙无面筋、无糖、对酮友好的产品。Eshbal的无麸质产品在以色列各地的几乎每一家超市以及其他食品零售商和健康商店都可以找到。

Yoav Bar-Joseph, CEO and director of Cannibble: "The proposed acquisition of Eshbal will mark a significant step in Cannibble's development and coincides with the growth in consumer demand for gluten/sugar-free products, vegan, dietary supplements, and milk and meat substitutes. Our intention with this proposed acquisition is to position Cannibble as a leader in the US health and wellness "better-for-you" market, which is predicted to reach US$298.3 billion in the year 2022 [1]."

食肉公司首席执行官兼董事首席执行官约阿夫·巴尔-约瑟夫:“拟议中的收购Eshbal将标志着食肉公司在发展中迈出了重要的一步,同时也与消费者对面筋/无糖产品、素食、膳食补充剂以及牛奶和肉类替代品的需求增长相吻合。我们提议进行此次收购的目的是将罐头公司定位为美国健康和保健产品市场的领导者,预计2022年这一市场规模将达到2983亿美元[1]."

Yuval Levy, Chairman of Eshbal Functional foods: "The merger of Eshbal and Cannibble directly fits the strategy of both companies. Eshbal brings unique know-how and food technology while Cannibble brings North American market experience and presence. We believe that the accumulated experience of both managements will drive market success and quick growth of the combined company in this high growth sector of "better-for-you" food products."

Eshbal功能食品公司董事长尤瓦尔·利维:“Eshbal和Cannibble的合并直接符合两家公司的战略。Eshbal带来了独特的技术诀窍和食品技术,而Cannibble带来了北美市场经验和存在。我们相信,两家管理层积累的经验将推动合并后的公司在这个‘对你更好’的高增长食品领域取得市场成功和快速增长。”

Acquisition Terms

收购条款

It is anticipated that the Proposed Acquisition will be an all shares transaction, with the Vendors receiving in the aggregate ordinary shares of Cannibble ("Cannibble Shares") equal to 50% of the issued and outstanding Cannibble Shares at closing of the Proposed Acquisition ("Closing"), and with Cannibble issuing up to another 20% (of the number of Cannibble Shares issued and outstanding at Closing) of Cannibble Shares to the Vendors subject to Eshbal achieving certain sales or profitability milestones within six years of Closing. The Proposed Acquisition is expected to be a fundamental acquisition for Cannibble under the policies of the Canadian Securities Exchange ("CSE") and will be subject to CSE and Cannibble shareholder approval. Following Closing, Eshbal will be a wholly-owned subsidiary of Cannibble. At Closing, it is expected that Yuval Levy will join the board of Cannibble as chairman and Ronit Vivante will join Cannibble as chief financial officer.

预计拟议的收购将是一项全股票交易,卖方总共将获得Cannibble的普通股(Cannibble股票“)相当于拟议收购完成时已发行和已发行的Cannibble股份的50%(”结业“),Cannibble将向供应商发行至多20%的Cannibble股票(成交时已发行和已发行的Cannibble股票数量),但Eshbal必须在交易完成后六年内实现一定的销售或盈利里程碑。根据加拿大证券交易所(Canada Securities Exchange)的政策,拟议中的收购预计将是Cannibble的一项基本收购(”CSE“),并将得到CSE和Cannibble股东的批准。完成交易后,Eshbal将成为Cannibble的全资子公司。在完成交易时,预计Yuval Levy将加入Cannibble董事会担任董事长,Ronit Vivante将加入Cannibble担任首席财务官。

The completion of the Proposed Acquisition is subject to the negotiation and signing of a definitive agreement in respect of the Proposed Acquisition, completion of due diligence by the parties, completion of a private placement by Cannibble of a minimum financing of C$4,000,000 (the "Minimum Financing"), receipt of all applicable governmental, regulatory and contractual third party approvals, including approval of the Canadian Securities Exchange, and other conditions precedent and closing conditions customary for similar transactions to the Proposed Acquisition.

拟议收购的完成取决于谈判和签署关于拟议收购的最终协议、各方完成尽职调查、由Cannibble完成最低融资4,000,000加元(“最低融资额“),获得所有适用的政府、监管和合同第三方批准,包括加拿大证券交易所的批准,以及与拟议收购类似交易的其他先决条件和成交条件。

About Cannibble

关于卡尼勃

Cannibble is a food-tech company that develops and manufactures food and beverage products variously enhanced with hemp seeds, hemp protein, and other hemp ingredients, where legal to do so. Cannibble has developed proprietary formulas for food and beverage products enhanced with hemp seeds and protein, targeted for the "Better-for-You" segment. The products are sugar free, dairy free, plant based, non GMO, and marketed under Cannibble's brand name "The Pelicann™".

Cannibble是一家食品科技公司,在合法的情况下,开发和制造使用大麻种子、大麻蛋白和其他大麻成分增强的食品和饮料产品。Cannibble已经为食品和饮料产品开发了专有配方,这些产品使用大麻种子和蛋白质增强,目标是“对你更好”的细分市场。这些产品是无糖、无乳制品、植物性、非转基因的,并以食人鱼的品牌名称“The Pelicann™”销售。

Cannibble has developed over 100 product SKUs, of which 40 have been manufactured to date. For more information about Cannibble and its business, visit .

Cannibble已经开发了100多个产品SKU,其中40个到目前为止已经生产出来。有关Cannibble及其业务的更多信息,请访问。

About Eshbal

关于以实巴勒

Eshbal develops and produces unique formulations of: nutraceuticals, medicinal foods, sugar-free and gluten-free products, vegan products, syrups, and dry mixes including sweeteners and a line of keto products. Eshbal focuses on the development of unique formulations of functional food products that it believes promote health beyond their nutritional values for retail brands, private labels, and B2B. Eshbal's products can be found in almost every supermarket as well as other food retailers and health stores throughout Israel. For firther information see Eshbal's website at .

Eshbal开发和生产以下产品的独特配方:营养食品、药用食品、无糖和无麸质产品、素食产品、糖浆以及包括甜味剂和一系列酮类产品在内的干混合物。Eshbal专注于开发独特的功能性食品配方,它认为这些产品不仅可以促进零售品牌、自有品牌和B2B的营养价值,还可以促进健康。Eshbal的产品在以色列各地的几乎每一家超市以及其他食品零售商和健康商店都可以找到。有关更多信息,请参见Eshbal的网站。

Yoav Bar-Joseph, CEO and director
Email: yoav.b@cannibble.world
Tel: +1 (786) 322 6055

董事首席执行官约阿夫·巴尔-约瑟夫
电子邮件:yoav.b@canibble.world
电话:+1(786)322 6055

Cautionary Statement

警示声明

Certain statements in this news release constitute "forward-looking information" under applicable Canadian securities laws. Words such as plan, anticipate, believe, estimate, expect, may, intend, and similar expressions, as they relate to Cannibble or its management, identify forward-looking information. Forward-looking information in this news release relates to the Proposed Acquisition and the benefits that Cannibble expects to realize from the Proposed Acquisition, Cannibble's expectations for growth of the global health and wellness market and the timing for these future events. Cannibble can give no assurance that it will be successful in completion the Proposed Acquisition. Forward‐looking information is based on a number of assumptions and is subject to a number of risks and uncertainties, many of which are beyond Cannibble's control, which could cause actual results and events to differ materially from those that are disclosed in or implied by such forward‐looking information. Risks associated with the Proposed Acquisition include those related to the parties' ability to negotiate and sign a definitive agreement, obtain the necessary shareholder and regulatory approvals, complete the Minimum Financing, and the timing for the completion of all these events, as well as the risk, assuming the Proposed Acquisition does complete, that the anticipated benefits of the Proposed Acquisition do not materialize. Cannibble does not undertake any obligation to update such forward‐looking information whether because of new information, future events or otherwise, except as expressly required by applicable law.

根据适用的加拿大证券法,本新闻稿中的某些陈述构成“前瞻性信息”。像这样的词计划、预期, 相信, 估算, 期望的、可能的、打算的,以及类似的表述,当它们与Cannibble或其管理有关时,识别前瞻性信息。本新闻稿中的前瞻性信息涉及拟议的收购和Cannibble预计从拟议的收购中实现的好处,Cannibble对全球健康和保健市场增长的预期,以及这些未来活动的时机。Cannibble不能保证它将成功完成拟议中的收购。前瞻性信息基于许多假设,受许多风险和不确定因素的影响,其中许多风险和不确定因素超出了Cannibble的控制范围,可能导致实际结果和事件与前瞻性信息中披露或暗示的情况大不相同。与拟议收购相关的风险包括与各方谈判和签署最终协议、获得必要的股东和监管机构批准、完成最低融资以及完成所有这些事件的时间的能力有关的风险,以及假设拟议收购确实完成的风险,即拟议收购的预期收益没有实现。除非适用法律明确要求,否则由于新信息、未来事件或其他原因,Cannibble不承担更新此类前瞻性信息的任何义务。

[1]

[1]

To view the source version of this press release, please visit

要查看本新闻稿的源版本,请访问

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发